A comparison of neoadjuvant chemotherapy with gemcitabine versus docetaxel plus cisplatin in locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis

References

• CaoSMSimonsMJQianCNThe prevalence and prevention of nasopharyngeal carcinoma in ChinaChin J Cancer201130211411921272443
   PubMedGoogle Scholar
• ChanATNasopharyngeal carcinomaAnn Oncol201021Suppl 7vii308vii31220943634
   PubMedGoogle Scholar
• ChanATTeoPMJohnsonPJNasopharyngeal carcinomaAnn Oncol20021371007101512176778
   PubMed Web of Science ®Google Scholar
• LeeAWSzeWMAuJSTreatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experienceInt J Radiat Oncol Biol Phys20056141107111615752890
   PubMed Web of Science ®Google Scholar
• SanguinetiGGearaFBGardenASCarcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional controlInt J Radiat Oncol Biol Phys19973759859969169804
   PubMed Web of Science ®Google Scholar
• Al-SarrafMLeBlancMGiriPGChemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099J Clin Oncol1998164131013179552031
   PubMed Web of Science ®Google Scholar
• ShahBAQureshiMMJalisiSAnalysis of decision making at a multidisciplinary head and neck tumor board incorporating evidence-based National Cancer Comprehensive Network (NCCN) guidelinesPract Radiat Oncol20166424825426777060
   PubMed Web of Science ®Google Scholar
• LaiSZLiWFChenLHow does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?Int J Radiat Oncol Biol Phys201180366166820643517
   PubMed Web of Science ®Google Scholar
• SunXSuSChenCLong-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicitiesRadiother Oncol2014110339840324231245
   PubMed Web of Science ®Google Scholar
• ChuaDTMaJShamJSLong-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trialsJ Clin Oncol20052361118112415657403
   PubMed Web of Science ®Google Scholar
• FountzilasGCiuleanuEBobosMInduction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluationAnn Oncol201223242743521525406
   PubMed Web of Science ®Google Scholar
• HuiEPMaBBLeungSFRandomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinomaJ Clin Oncol200927224224919064973
   PubMed Web of Science ®Google Scholar
• XieFYQiSNHuWHSnQWhHComparison of efficacy of docetaxel combined cisplatin (TP regimen) and cisplatin combined 5-fluorouracil (PF regimen) on locally advanced nasopharyngeal carcinomaAi Zheng2007268880884 Chinese17697552
   PubMedGoogle Scholar
• AiroldiMGabrielePGabrieleAMInduction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinomaCancer Chemother Pharmacol20116751027103420644931
   PubMed Web of Science ®Google Scholar
• GoldenDWRudraSWittMEOutcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinomaOral Oncol201349327728223102863
   PubMed Web of Science ®Google Scholar
• SunYLiWFChenNYInduction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicen-tre, randomised controlled trialLancet Oncol201617111509152027686945
   PubMed Web of Science ®Google Scholar
• KongLZhangYHuCGuoYLuJJEffects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: final results of 2 parallel phase 2 clinical trialsCancer2017123122258226728192641
   PubMed Web of Science ®Google Scholar
• WangFZJiangCEWangLAddition of 5-fluorouracil to first-line induction chemotherapy with docetaxel and cisplatin before concurrent chemoradiotherapy does not improve survival in locoregionally advanced nasopharyngeal carcinomaOncotarget2017853911509116129207632
   PubMedGoogle Scholar
• ZhangLHuangYHongSGemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trialLancet2016388100541883189227567279
   PubMed Web of Science ®Google Scholar
• NganRKYiuHHLauWHCombination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II studyAnn Oncol20021381252125812181249
   PubMed Web of Science ®Google Scholar
• MaBBTannockIFPondGRChemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinomaCancer200295122516252312467065
   PubMed Web of Science ®Google Scholar
• WangJLiJHongXRetrospective case series of gemcitabine plus cisplatin in the treatment of recurrent and metastatic nasopharyngeal carcinomaOral Oncol200844546447017826303
   PubMed Web of Science ®Google Scholar
• HeXOuDYingHExperience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinomaEur Arch Otorhinolaryngol201226931027103321706324
   PubMed Web of Science ®Google Scholar
• JamshedAHussainRIqbalHGemcitabine and cisplatin followed by chemo-radiation for advanced nasopharyngeal carcinomaAsian Pac J Cancer Prev201415289990424568516
   PubMedGoogle Scholar
• WangFZSunQQJiangCEGemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinomaOncotarget2017857967989680829228572
   PubMedGoogle Scholar
• ZhengWQiuSHuangLPanJIs Gemcitabine and cisplatin induction chemotherapy superior in locoregionally advanced nasopharyngeal carcinoma?Pak J Med Sci201531478178626430402
   PubMed Web of Science ®Google Scholar
• EdgeSBComptonCCThe American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNMAnn Surg Oncol20101761471147420180029
   PubMed Web of Science ®Google Scholar
• LeeNHarrisJGardenASIntensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225J Clin Oncol200927223684369019564532
   PubMed Web of Science ®Google Scholar
• AustinPCThe relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studiesMed Decis Making200929666167719684288
   PubMed Web of Science ®Google Scholar
• ChanATTeoPMNganRKConcurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trialJ Clin Oncol20022082038204411956263
   PubMed Web of Science ®Google Scholar
• LeeAWTungSYChuaDTRandomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinomaJ Natl Cancer Inst2010102151188119820634482
   PubMed Web of Science ®Google Scholar
• LinJCJanJSHsuCYPhase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survivalJ Clin Oncol200321463163712586799
   PubMed Web of Science ®Google Scholar
• ChenYLiuMZLiangSBPreliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of chinaInt J Radiat Oncol Biol Phys20087151356136418472356
   PubMed Web of Science ®Google Scholar
• WeeJTanEHTaiBCRandomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varietyJ Clin Oncol200523276730673816170180
   PubMed Web of Science ®Google Scholar
• LinSPanJHanLNasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective seriesInt J Radiat Oncol Biol Phys20097541071107819362784
   PubMed Web of Science ®Google Scholar
• LeeAWLauKYHungWMPotential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinomaRadiother Oncol200887220421018329742
   PubMed Web of Science ®Google Scholar
• HareyamaMSakataKShiratoHA prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinomaCancer20029482217222312001120
   PubMed Web of Science ®Google Scholar
• OuXZhouXShiQTreatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boostOncotarget2015635383813839726485757
   PubMedGoogle Scholar
• TianRYeHXZhangBGUse of taxane-containing induction chemotherapy in combination with concurrent chemoradiotherapy in Chinese patients with locally advanced nasopharyngeal carcinoma: a meta-analysisOnco Targets Ther201583255326326604792
   PubMed Web of Science ®Google Scholar
• ZhangLNGaoYHLanXWEffect of taxanes-based induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: a large scale propensity-matched studyOral Oncol2015511095095626209065
   PubMed Web of Science ®Google Scholar
• ZhaoLXuMJiangWInduction chemotherapy for the treatment of non-endemic locally advanced nasopharyngeal carcinomaOncotarget2017846763677428036270
   PubMedGoogle Scholar
• StürmerTJoshiMGlynnRJAvornJRothmanKJSchneeweissSA review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methodsJ Clin Epidemiol200659543744716632131
   PubMed Web of Science ®Google Scholar